Загрузка...
PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2
BACKGROUND: In the last years, the transmembrane proteoglycan NG2 has gained interest as a therapeutic target for the treatment of diverse tumor types, including gliomas, because increases of its expression correlate with dismal prognosis. NG2 has been shown to function as a co-receptor for PDGF lig...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2964636/ https://ncbi.nlm.nih.gov/pubmed/20939912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-550 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|